Upload
dody-firmanda
View
219
Download
0
Embed Size (px)
Citation preview
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
1/32
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
2/32
IC^A]K PALC^KHCODLKOKDCL PC^HUC[T ]TQN N] IJHCICN TQUCONKA
GJ^C TQ]CMC[CBCUC ^KIQ]
N}/ Njn{ Fk}iconc, Tp/C, ICTq}cmc{c, 8 ; Nataima} =03=
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
3/32
k
Ncf~c} Ktk
HclcicoPaonchqlqco Dlkokdcl Pc~huc{t 3
Icofcc~ Dlkokdcl Pc~huc{t nc}k taek Afktkaotk Paimkc{cco, Afag~kfk~ct Palc{coco ncoGama}cnklco*Agqk~k nclci ^c~c Galjlc Glkokt (Dlkokdcl Ejva}ocoda+ nco Tkt~aiPaimkc{cco Dctaikx
T~conc} Palc{coco Ganjg~a}co (TPG+, Panjico Octkjocl Palc{cocoGanjg~a}co (POPG+, T~conc} P}jtanq} Jpa}ctkjocl (TPJ+ nco PconqcoP}cg~kg Glkokt (PPG+Pa}co Dlkokdcl Pc~huc{t nclci Iq~q nk ]qich Tcgk~Pa}co Dlkokdcl Pc~huc{t nclci Paonknkgco Gatahc~co*Ganjg~a}co nk ]qichTcgk~Pa}co Dlkokdcl Pc~huc{t nclci Paoalk~kco Gatahc~co*Ganjg~a}co nk ]qichTcgk~Icofcc~ Dlkokdcl Pc~huc{t nclci Cg}ank~ctk ]qich Tcgk~
>
P}kotkp P}kotkp nclci Iao{qtqo Dlkokdcl Pc~huc{t =4
Lcoegch Lcoegch Pao{qtqoco Dlkokdcl Pc~huc{t =>
Pa}tkcpco nclci Pao{qtqoco Dlkokdcl Pc~huc{t =1
Gatkipqlco =6
Lcipk}co2Fj}ic~ Pconqco P}cg~kg Glkokt (PPG+ ]TQN N} Ijhcicn Tquconka =8
Fj}ic~ Qiqi Dlkokdcl Pc~huc{t ]TQN N} Ijhcicn Tquconka 40
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
4/32
3
Dlkokdcl Pc~huc{t $
Njn{ Fk}iconcGa~qc Gjik~a Iankg ]TQP Fc~icuc~k, Bcgc}~c/
Paonchqlqco
Nclci ialcgqgco avclqctk gamkbcgco nco tkt~ai lc{coco gatahc~co ( hacl~hdc}a t{t~ai
con pjlkdkat avclqc~kjo+ ~a}ictqg }qcich tcgk~ cnc 4 g}k~a}kc gqodk {cgok g}k~a}kc
afag~kfk~ct, afktkaotk, nco gama}cnklco*agqk~k(affad~kvaoatt, affkdkaod{ con asqk~{+3 {coe
ia}qpcgco tqc~q }coegckco tkt~aic~kg nclci tqc~q tkt~ai/ Ialcgqgco tqc~q coclktkt
agjojik nclci palc{coco ganjg~a}co p}jfatk cnclch ~kncg iqnch, iaoekoec~ mco{cg
fcg~j} {coe hc}qt nkpa}~kimcoegco nc}k ma}mceck nkiaotk ~a}ictqg dc}c paonagc~co nc}k
baokt coclktkt agjojik {coe cgco nkeqocgco, mc~ctco ~a}ikojljek agjojik k~q taonk}k
iaoeaock q~klkrc~kjo, p}jnqd~kvk~{, maoafk~, affkdkaod{, affad~kvaoatt, vclqa fj} ijoa{,
gamkbcgco fktgcl nco ~koegc~koflc~kjo }c~a {coe ta}koe gclk ma}qmch/ Nktcipkoe
ga~a}mc~ctco tqima} nc{c nco gamkbcgco agjojik {coe nkpaoec}qhk pjlk~kt, tahkoeec
~kncg bc}coe%}atjq}dat% ~a}tamq~ ~alch nkpceq iaobcnk%fkxan% /=
Tancoegco nk tktk nkiaotk lcko p}jfatk k~q taonk}k nk~qo~q~ qo~qg iaokoegc~gco iq~q
palc{cocoo{c nco gap}jfatkcoo{c nclci gj}knj} a~kg)tjtkj)mqnc{c ta}~c ma}mceck
pa}c~q}co nco pa}qoncoeco hqgqi/ 5 Pctcl >1 nclci Qoncoe Qoncoe ]K Ojij} =;
^chqo =00> ~ao~coe P}cg~kg Ganjg~a}co pcnc iaoa}coegco ~ao~coe gaucbkmco
iao{alaoeec}cgco gaonclk iq~q nco gaonclk mkc{c 4 nco Qoncoe Qoncoe ]K Ojij}
$ Nktcipckgco pcnc Uj}gthjp Dlkokdcl Pc~huc{t ]TQN N} Ijhcicn Tquconka Tq}cmc{cBcuc ^kiq} 8 ) ; Nataima} =03=/
3 Cnc{ LC, Maela{ DA, Lck}tjo N]/ Avclqc~koe ~ha hacl~hdc}a t{t~ai2 affad~kvaoatt, affkdkaod{ conasqk~{/ 4}n an/ Ucthkoe~jo ND2 Hacl~h Cnikokt~}c~kjo P}att, =00>/
= Fk}iconc N/ Cplkgctk ko~ae}ctk tkoa}ekt co~c}cAvknaova)mctan Iankdkoa, Avknaoda)mctan Hacl~hdc}a nco Avknaoda)mctan Pjlkd{ nclci tc~q tkt~ai paokoegc~co iq~q palc{coco gatahc~co nco ganjg~a}co(Dlkokdcl Ejva}ocoda+2 tqc~q ~co~coeco p}jfatk KNCK nk ictc iaonc~coe/KK/Djt~ Affad~kvaoatt Cocl{tat(DAC+T~conc} Palc{coco Iankt (TPI+ Gatahc~co Cocg KNCK Nktcipckgco pcnc Cdc}c Pa}~aiqcoPa}hkipqoco J}ecoktctk P}jfatk naoeco Nk~bao [co Iankg Napgat ]K nk Mjej} Tap~aima} =001/h~~p2**uuu/td}kmn/dji*njd*3=8=5;46*Njn{)Fk}iconc)=001)0>=)Cplkgctk)ko~ae}ctk)tkoa}ekt)
Avknaovamctan)Iankdkoa)Avknaodamctan)Hacl~hdc}a)nco)Avknaodamctan)Pjlkd{)nclci)Dlkokdcl)Ejva4 Qoncoe Qoncoe ]K Ojij} =; ^chqo =00> ~ao~coe P}cg~kg Ganjg~a}co
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
5/32
=
>> ^chqo =030 ~ao~coe ]qich Tcgk~ pcnc pctcl 44 iaoa}coegco ~ao~coe j}ecoktctk
}qich tcgk~ {coe afag~kf, afktkao, nco cgqo~cmal / >
Tancoegco nclci paoealjlcco gaqcoeco ~alch cnc Pa}c~q}co Paia}ko~ch Ojij} =4
^chqo =001 ~ao~coe Paoealjlcco Gaqcoeco Mcnco Lc{coco Qiqi nco Pa}c~q}co
Iao~a}k Nclci Oaea}k Ojij} 63 ^chqo =005 ~ao~coe Panjico ^agokt Paoealjlcco
Gaqcoeco Mcnco Lc{coco Qiqi Nca}ch pcnc pctcl 3 c{c~ 3 iao{amq~gco qo~qg
iaima}kgco palc{coco gapcnc ict{c}cgc~ ma}qpc pao{ankcco mc}coe nco*c~cq bctc {coe
nkbqcl ~copc iaoeq~cicgco iaodc}k gaqo~qoeco nco nclci ialcgqgco gaekc~coo{c
nknctc}gco pcnc p}kotkp afktkaotk nco p}jnqg~kvk~ct /1,6
Naoeco ~a}mk~o{c Qoncoe Qoncoe ]apqmlkg Konjoatkc Ojij} => ^chqo =033 ~ao~coe
Mcnco Pao{alaoeec}c Bcikoco Tjtkcl (MBPT+ 5/ Tatqck naoeco cicoc~ pa}qoncoeco
~a}tamq~ ) pa}c~q}co iaoeaock palcgtcocco MPBT Gatahc~co hc}qt ~alch cnc pclkoe lcic
~coeecl =1 Ojvaima} =03= (3 ~chqo nc}k nkqoncoegcoo{c+ 8 nco tqnch hc}qt iqlck
ma}jpa}ctk pcnc ~coeecl 3 Bcoqc}k =03>; ta}~c qo~qg MPBT Gatahc~co30 ~kncg
nktalaoeec}cgco lcek jlah Gaiao~a}kco Gatahc~co 33 / Pa}~co{cco {coe ~kimql cnclch
mceckicoc tkt~ai MPBT Gatahc~co ~a}tamq~:
Avjlqtk tkt~ai lc{coco gatahc~co nk tc}coc gatahc~co (}qich tcgk~+ tadc}c p}kotkpo{c
iqlck nc}k {coe ma}dk}kgco njkoe ~hkoet dhacpa} nclci hcl kok affkdkaod{pcnc ~chqo
3;50co pcnc ucg~q g}ktkt gaqcoeco nco eabjlcg JPAD, gaiqnkco agjojik iqlck pqlkh
nco ict{c}cgc~ iaoqo~q~ lc{coco gatahc~co ma}dk}kgco njkoe ~hkoet ma~~a} nclci hcl
koksqclk~{ kip}jvaiao~ / Talcic nqc nagcna ~a}tamq~ icocbaiao ma}dj}cg njkoe ~hkoet
}keh~ (nkgaocl tamceck kod}actkoe affad~kvaoatt+{coe ia}qpcgco gjimkoctk njkoe
> Qoncoe Qoncoe ]K Ojij} >> ^chqo =030 ~ao~coe ]qich Tcgk~1 Pa}c~q}co Paia}ko~ch ]K Ojij} =4 ^chqo =001 ~ao~coe Paoealjlcco Gaqcoeco Mcnco Lc{coco Qiqi6 Pa}c~q}co Iao~a}k Nclci Oaea}k Ojij} 63 ^chqo =005 ~ao~coe Panjico ^agokt Paoealjlcco Gaqcoeco
Mcnco Lc{coco Qiqi Nca}ch5 Qoncoe Qoncoe ]K Ojij} => ^chqo =033 ~ao~coe Mcnco Pao{alaoeec}c Bcikoco Tjtkcl8 Qoncoe Qoncoe ]K Oj/=> ^chqo =033 Pctcl 50 c{c~ c/; Qoncoe Qoncoe ]K Oj/=> ^chqo =033 Pctcl 60 c{c~ (3+/30 Qoncoe Qoncoe ]K Oj/=> ^chqo =033 Pctcl 1 c{c~ (=+c/33 Qoncoe Qoncoe ]K Oj/=> ^chqo =033 Pctcl 60 c{c~ (=+c/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
6/32
4
~hkoet dhacpa} nco njkoe ~hkoet ma~~a}/ a}o{c~c p}kotkp njkoe ~hkoet }keh~ ~kncg
iaicnck iaoekgq~k pa}gaimcoeco gaicbqco ~agojljek icqpqo ~qo~q~co ict{c}cgc~
{coe taicgko g}k~kt7 nco p}kotkp icocbaiao njkoe ~hkoet }keh~ ~a}tamq~ ~alch
ga~koeeclco rcico nco nkcoeecp tamceck p}kotkp nco dc}c icocbaiao gqoj/ Pcnc cmcn =3
kok ictc a}c eljmclktctk nkmq~qhgco ~kncg hco{c njkoe ~hkoet }keh~, cgco ~a~cpk bqec
nkpa}lqgco p}kotkp icocbaiao njkoe ~ha }keh~ ~hkoet tahkoeec gjimkoctk ganqco{c
nktamq~ tamceck p}kotkp icocbaiao lc{coco ijna}o njkoe ~ha }keh~ ~hkoet }keh~ / 3=
Icofcc~ Dlkokdcl Pc~huc{t nclci Afktkaotk Paimkc{cco, Afag~kfk~ct Palc{coco ncoGama}cnklco*Agqk~k
Dlkokdcl Pc~huc{t (DP+ cnclch tqc~q gjotap pa}aodcocco palc{coco ~a}pcnq {coe
ia}coegqi ta~kcp lcoegch {coe nkma}kgco gapcnc pctkao ma}nctc}gco t~conc}
palc{coco iankt nco ctqhco gapa}cuc~co {coe ma}mctkt mqg~k naoeco hctkl {coe ~a}qgq}
nco nclci bcoegc ucg~q ~a}~ao~q talcic nk }qich tcgk~/ 34,3>,31
Ma}kgq~ hctkl paoalk~kco paoa}cpcoDlkokdcl Pc~huc{t Poaqijokc (Ecimc} 3 nco =+ {coe
nklcgqgco nclci }coegc iaimqg~kgco cnco{c afktkaotk mkc{c, afag~kfk~ct lc{coco nco
gama}cnklco*agqk~k mcek taiqc pctkao ~copc iaiconcoe lc~c} malcgcoe gacncco tjtkcl
agjojik, paonknkgco icqpqo eaona}/ Nc}k Ecimc} 3 nco = nk mcuch qo~qg gctqt
poaqijokc mkc{c pa}cuc~co tcipck taimqh (naoeco ~c}kf }qich tcgk~+ iaipa}eqocgco
Dlkokdcl Pc~huc{t Poaqijokc cnclch tagk~c} ]p >;1 000,) qo~qg galct KKK, ]p 3 3=0 000,)
qo~qg galct KK, ]p 3 >80 000,) qo~qg galct K nco ]p = 310 000,) qo~qg galct VKP/
3= Fk}iconc N/ Pa}co Afag~kfk~ct Glkokt nclci }coegc iauqbqngco gatalcic~co*gacicoco (tcfa~{+ nco ma}j}kao~ctk gapcnc pctkao (pc~kao~ dao~}anoatt+/Nktcipckgco pcnc Hjtpk~cl Icoceaiao~ 4 {coenktalaoeec}cgco jlah Pqtc~ Gcbkco Cnikokt~}ctk nco Gamkbcgco Gatahc~co FGI QK nk E}con CoegctcHj~al Ko~a}oc~kjocl, Ianco 33 Ceqt~qt =008/ h~~p2**uuu/td}kmn/dji*njd*;834333*Njn{)Fk}iconc)=008)
Pa}co)Afag~kvk~ct)Glkokt)Nclci)PC^H34 Fk}iconc N/ Panjico Pao{qtqoco Dlkokdcl Pc~huc{t nclci }coegc kiplaiao~ctk Tkt~ai N]Et
Dctaikx nk }qich tcgk~/ Nktcipckgco nclci Tkncoe Plaoj Gjik~a Iankg ]T Fc~icuc~k, Bcgc}~c 5Jg~jma} =001/
3> Fk}iconc N/ Dlkokdcl Pc~huc{t2 Pa}co p}jfatk iankt nclci }coegc iao{qtqo Tkt~ai N]Et Dctaikx nk}qich tcgk~/ Nktcipcgco pcnc gqobqoeco lcpcoeco ga ]TQP Cnci Iclkg Ianco == Nataima} =001,]TQP Hctco Tcnkgko Mconqoe =4 Nataima} =001 nco Avclqctk Pao{qtqoco Dlkokdcl Pc~huc{t nclci}coegc pao{aipq}occo Panjico N]Et Dctaikx Napgat ]K, Hj~al E}con Daipcgc Bcgc}~c =;Nataima} =001/
31 Fk}iconc N, P}c~kuk Conc{cok, Oq}ckok K}ic Tqtco~k, T}ka Aoeec} GN ngg/ Dlkokdcl Pc~huc{tGatahc~co Cocg nclci }coegc kiplaiao~ctk Tkt~ai N]Et Dctaikx nk ]T Fc~icuc~k, Bcgc}~c =006/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
7/32
>
Tancoegco mklc nkhk~qoe ma}nctc}gco glcki Bcigatict qo~qg gctqt {coe tcic cnclch ]p
= 505 664,)/ Icgc tadc}c ic~aic~kg naoeco iaipa}eqocgco Dlkokdcl Pc~huc{t qo~qg
gctqt poaqijokc ~a}tamq~ iaoehaic~ (= 505 664 >;1 000 9 ]p = =3= 664,)+/ Naoeco
naikgkco ~a}lkhc~ balct nc}k taek agjojik*paimkc{cco }qich tcgk~ ~a}tamq~ tcoec~ afktkao
nco iaoeqo~qoegco mklc iaoeeqocgco Dlkokdcl Pc~huc{t /
Naoeco iaipa}eqocgco Dlkokdcl Pc~huc{t ncpc~ iaoehk~qoe Djt~ Uakeh~ ta~kcp
galjipjg gctqt, djo~jh qo~qg gctqt poaqijokc nk c~ct }a}c~c tqima}nc{c (}atjq}dat+
}qich tcgk~ (jmc~ jmc~co, mchco nco clc~ nll+ {coe ~a}pcgck cnclch]p =10 000,) icgc
Djt~)Uakeh~ o{c cnclch (>10 000*=10 000 9 3/8+ /
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
8/32
1
Ecimc} 3/ Djo~jh hctkl paoalk~kco kiplaiao~ctk tclch tc~q Dlkokdcl Pc~huc{t qo~qg gctqt poaqijokc
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
9/32
6
Ecimc} =/ Djo~jh coclktkt hctkl kiplaiao~ctk tclch tc~q Dlkokdcl Pc~huc{t pcnc~chqo =006 qo~qg gctqt poaqijokc
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
10/32
5
^ao~coe dc}c lcoegch lcoegch pa}hk~qoeco djt~ uakeh~, dctaikx konax, mcta }c~a
}qich tcgk~ nco cljgctk coeec}co ncpc~ nklkhc~ nclci Ecimc} 4 ma}kgq~/
Ecimc} 4/ Djo~jh pa}hk~qoeco ma}nctc}gco nc~c hctkl kiplaiao~ctk Dlkokdcl Pc~huc{t nclci iaodc}k ]alc~kva Uakeh~ (djt~ uakeh~+, Dcta Ikx Konax nco Mcta ]c~a /
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
11/32
8
Cec} ~kncg ~qipcoe ~konkh ta}~c tkoa}ekt naoeco gao{c~cco nk lcpcoeco (}qich
tcgk~+, icgc kiplaiao~ctk Dlkokdcl Pc~huc{t tamckgo{c ~a}pcnq naoeco ~c~cgaljlc
icocbciao (dj}pj}c~a ejva}ocoda+ nco ~c~cgaljlc glkokt (dlkokdcl ejva}ocoda +
{coe ~alch ma}lcgq tatqck iktk }qich tcgk~ nclci mkncoe palc{coco, paonknkgco
nco paoalk~kco/
Naoeco ~a}mk~o{c Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij}
34>8*IAOGAT*PA]*KX*=030 {coe nkeqocgco cnclch kt~klch T~conc} Palc{coco
Ganjg~a}co (TPG+ {coe ~a}nk}k nc}k Panjico Octkjocl Palc{coco Ganjg~a}co
(POPG+ nco T~conc} P}jtanq} Jpa}ctkjocl (TPJ+/ POPG nkmqc~ jlah j}ecoktctk p}jfatk nco nktchgco jlah Iao~a}k Gatahc~co ]K, tancoegco TPJ nkmqc~ nk ~koegc~
}qich tcgk~ jlah p}jfatk iankt naoeco gjj}nkoc~j} Gjik~a Iankt nco nk~a~cpgco
paoeeqoccoo{c nk }qich tcgk~ ~a}tamq~ jlah pkipkoco (nk}ag~q}+/
T~conc} P}jtanq} Jpa}ctkjocl qo~qg p}jfatk iankt nk }qich tcgk~ nclci mao~qg
Pconqco P}cg~kg Glkokt36 ) pcnc qiqio{c ncpc~ nkcnjptk nc}k Pconqco Octkjocl
Palc{coco Ganjg~a}co (POPG+ {coe ~alch nkmqc~ jlah j}ecoktctk p}jfatk ictkoe
ictkoe, ~koeecl nkdjdjggco nco nktatqckgco naoeco gjonktk tc}coc nco
gjipa~aotk {coe cnc nk }qich tcgk~/ Mklc POPG {coe ~alch nkmqc~ jlah j}ecoktctk
p}jfatk ~a}tamq~ nco ~alch nktchgco jlah Iao~a}k Gatahc~co ]K ta}~c tatqck naoeco
gjonktk }qich tcgk~ icgc ~koeecl nktapcgc~k jlah coeej~c p}jfatk (TIF+ ~a}gck~
tamceck Pconqco P}cg~kg Glkokt (PPG+ nco nktchgco paoeeqoccoo{c nk }qich
tcgk~ jlah nk}ag~q} }qich tcgk~ ~a}tamq~/
Ociqo mklc POPG ~a}tamq~ malqi cnc c~cq ~kncg tatqck naoeco gjonktk }qich
tcgk~ c~cq nclci POPG malqi iaodco~qigco baokt pao{cgk~ {coe tatqck naoeco
gacncco apknaikjljek pao{cgk~ nk nca}ch*}qich tcgk~ ~a}tamq~ icgc p}jfatk nk
}qich tcgk~ ~a}tamq~ ucbkm iaimqc~ Pconqco P}cg~kg Glkokt (PPG+ qo~qg }qich
tcgk~ ~a}tamq~ nco nktchgco paoeeqoccoo{c nk }qich tcgk~ jlah nk}ag~q} }qich
tcgk~/ Nclci iao{qtqo POPG nc}k j}ecoktctk p}jfatk icqpqo PPG qo~qg }qich
36 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 34>8*IAOGAT*PA]*KX*=030
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
12/32
;
tcgk~ ) p}jfatk iankt iaima}kgco palc{coco gap}jfatkcoo{c tadc}c afag~kf (dlkokdcl
affad~kvaoatt+ nclci hcl iaoaecggco nkceojtkt nco iaima}kgco ~a}cpk
ma}nctc}gco paonagc~co avknaoda)mctan iankdkoa / Tadc}c tana}hcoc pa}c~q}co
~a}tamq~ ncpc~ nklkhc~ tamceckicoc nclci Ecimc} > ma}kgq~/
Ecimc} >/ ]koegctco Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 34>8*IAOGAT*PA]* KX*=030 ~ao~coe T~conc} Palc{coco Ganjg~a}co POPG,TPJ nco PPG/
P}jtat talcobq~o{c ta~alch iao{qtqo Pconqco P}cg~kg Glkokt (PPG+ ]qich Tcgk~
cnclch iaimqc~ Dlkokdcl Pc~huc{t tamceck tclch tc~q gjipjoao nc}k Tkt~ai
Dctaikx (KOC DME+ {coe tcc~ kok nkpa}eqocgco qo~qg Bcikoco Paialkhc}cco
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
13/32
30
Gatahc~co (Bcigatict+ nk }qich tcgk~ ) icgc KOC DME cgco lamkh
nktaipq}ocgco naoeco iaoehk~qoe N]E ]alc~kva Uakeh~ nco Dctaikx Konax
ta}~c Mcta ]c~a ta~kcp paoealjipjggco baokt pao{cgk~ nco talcobq~o{c ncpc~
iaimconkoegco (maodhic}gkoe+ djt~ affkdkaod{ co~c} }qich tcgk~ nclci
iaima}kgco lc{coco gatahc~co ma}nctc}gco gacncco tamaoc}o{c nkma}kgco ialclqk
Dlkokdcl Pc~huc{t /
Tkt~ai Dctaikx cnclch tqc~q dc}c iaoealjlc tqima} nc{c }qich tcgk~ taafag~kf
iqoegko nclci iaima}kgco lc{coco gatahc~co {coe ~a}bcoegcq gapcnc
ict{c}cgc~ ma}nctc}gco paoealjipjggco tpag~}qi nkceojtkt pao{cgk~ {coehjijeao nco p}jtanq} ~koncgco {coe nkma}kgco ) tadc}c }koegcto{c ~a}nk}k nc}k 4
gjipjoao q~cic {cgok gjnafkgctk nkceojtkt (KDN 30+ nco p}jtanq} ~koncgco
(KDN ; DI+, paimkc{cco ( djt~koe + {coe ncpc~ ma}qpc ~jp)njuo cpp}jcdh,
cd~kvk~{ mctan djt~koe nco c~cq gjimkoctk ganqco{c, nco ialclqk Dlkokdcl
Pc~huc{t /35,38,3;,=0,=3
KOC)N]E cnclch vc}kctk tkt~ai dctaikx va}tk Gaiao~a}kco Gatahc~co ]K qo~qg
Konjoatkc {coe nktqtqo ma}nctc}gco nc~c nc}k 31 }qich tcgk~ va}~kgcl,
iaipa}eqocgco KDN 30 qo~qg nkceojtkt nco KDN ; DI qo~qg p}jtanq} ~koncgco
ta}~c mkc{c ma}nctc}gco ~c}kf {coe ma}lcgq pcnc ucg~q ~a}tamq~/ Qpc{c ~a}tamq~
iaicoe malqi taipq}oc nco malqi iaoda}ikogco }aclk~ct gacncco talq}qh
paljtjg ~coch ck} ociqo tamceck ~k~kg ~joeecg cucl, hcl ~a}tamq~ ia}qpcgco
tqc~q gama}hctklco nclci iaimqc~ tqc~q tkt~ai paimkc{cco lc{coco gatahc~co
}qich tcgk~ nco qtchc mckg iaoqbq gapct~kco nco ncpc~ nkpa}mckgk ta}~c
nk~koegc~gco gqclk~ct icqpqo vclknk~ct nc~co{c {coe }ap}atao~c~kf qo~qg Konjoatkc/
35 Ejlnico L/ Djt~)Affad~kvaoatt ko c flc~ uj}ln Dco KDNt halp ~ha Qok~an T~c~at ea~ }h{~hi: O Aoel B Ian =0017414(3> +23134)1/
38 Ncoc M Iqgcia NM, Rucorkea} B, Mciarck C/ Hjtpk~cl djipa~k~kjo, }atjq}da clljdc~kjo consqclk~{ jf dc}a/ MID Hacl~h Ta}vkdat ]atac}dh =00=7 =(30+2 3>5=)83/
3; Nkcoa ]julcon N/ Iankdckn Kiplkdc~kjot fj} ~ha hacl~h tcfa~{ oa~/ O Aoel B Ian =0017414(3>+2 3>4;)>3/
=0 E}acll{ D/ Cf~a} 3= {ac}t jf Dctaikx ko K}alcon, c icbj} }avkau lacnkoe ~j k~t ijna}oktc~kjo conaxpcotkjo ct c dao~}cl pkllc} ko hjtpk~cl fqonkoe pjlkd{/ K}alcon Napc}~iao~ jf Hacl~h, =00>/
=3 Dctaikx Qok~ Napc}~iao~ jf Hacl~h con Dhkln}ao/ Dctaikx Iactq}aiao~ ko K}kth Hjtpk~clt/K}alcon Napc}~iao~ jf Hacl~h, =001/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
14/32
33
Tamceck tkt~ai {coe mc}q lchk} KOC)N]E cgco ~a}qt ma}eqlk} nco ma}gaimcoe
tatqck ~qo~q~co pa}gaimcoeco lc{coco gatahc~co mckg octkjocl icqpqo }aekjocl/ ==
Naoeco ma}cghk}o{c lktaotk e}jqpa} KOC)N]E ~a}hk~qoe ~coeecl 40 Tap~aima}
=030, icgc ocic tk~ai Dctaikx KOC)N]E ma}qmch iaobcnk KOC)DME =4/
P=BG Gaiao~a}kco Gatahc~co ]K ~alch iaoecncgco pa}~aiqco naoeco talq}qh
pa}hkipqoco p}jfatk nco gjlaekqi nk Naopctc} Mclk pcnc ~coeecl =4 Ojvaima}
=00; nco iaoehctklgco gapq~qtco tamceck ma}kgq~2
3/ Gatapcgc~co nco gjik~iao ma}tcic talq}qh pa}hkipqoco p}jfatk nco
Gjlaekqi ta~kcp pa}hkipqoco p}jfatk iaimqc~ 30 pao{cgk~ ~a}mco{cg
T~conc}*Panjico Palc{coco Iankt (T*PPI+ nco Dlkokdcl Pc~huc{t qo~qg
ialaoegcpk KOC)N]E nclci P}je}ci Bcikoco Gatahc~co/
=/ Pa}~aiqco talcobq~o{c ~coeecl == Bcoqc}k =030 nktalaoeec}cgco jlah Pqtc~
Paimkc{cco nco Bcikoco Gatahc~co (P=BG+ Tag}a~c}kc~ Baona}cl Napgat
]K iaimchct talq}qh TPI nco DP/
]aodcoc pa}~aiqco lcobq~co ~coeecl == Bcoqc}k =030 nkqonq} nco ~a}aclktctk pcnc
~coeecl 5); Cp}kl =030 nk Mc~ci naoeco paimchctco gaimclk iaoeaock T~conc}
Palc{coco Ganjg~a}co ta~kcp pa}hkipqoco p}jfatk/ Nc}k pa}~aiqco nkhc}cpgco
nkhctklgco tqc~q T~conc} Palc{coco Ganjg~a}co ~koegc~ octkjocl {coe nktamq~
Pconqco Octkjocl P}cg~kg Ganjg~a}co (POPG+ tamceckicoc {coe nkhc}cpgco nc}k
Pa}c~q}co Iao~a}k Gatahc~co Ojij} 3>48*IAOGAT*PA]*KX*=030 ~ao~coe
T~conc} Palc{coco Ganjg~a}co {coe cgco iaobcnk cdqco p}jfatk nk }qich tcgk~
qo~qg iaimqc~ Pconqco P}cg~kg Glkokt (PPG+ ictkoe ictkoe/
== Fk}iconc N/ Coclktkt Paimc{c}co gapcnc Paima}k Lc{coco Gatahc~co (PPG+ iaoeeqocgcoKOC)DME iaonagc~k hc}cpco taiqc pkhcg tatqck Dlkokdcl Pc~huc{t / Nktcipckgco pcncUj}gthjp Kiplaiao~ctk KOC)DME Pa}dapc~co ^}cotfj}ictk nk ]qich Tcgk~ Nca}ch (]TN+nktalaoeec}cgco jlah Ctjtkctk ]qich Tcgk~ Nca}ch Talq}qh Konjoatkc (C]TCNC+ Bcuc Mc}c~ nkHj~al Ct~jo ^}jpkdcoc Mconqoe, =4 Bqok =033/=4 Tq}c~ Anc}co Nk}ag~q} Baona}cl Mkoc Palc{coco Iankg Gaiao~a}kco Gatahc~co ]K Ojij} K]/04/03* K*150530 ^coeecl 38 Jg~jma} =030/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
15/32
3=
T~conc} Palc{coco Ganjg~a}co => cnclch panjico {coe hc}qt nkkgq~k jlah njg~a}
nclci iao{alaoeec}cgco p}cg~kg ganjg~a}co =1 nco tclch tc~q ~koncg lcobq~ nc}k
pa}qoncoeco {coe ~alch nk~a}mk~gcoaoci ~chqo {coe lclq/ =6 T~conc} Palc{coco
Ganjg~a}co ~a}nk}k nc}k Panjico Octkjocl Palc{coco Ganjg~a}co (POPG+ nco
T~conc} P}jtanq}cl Jpa}ctkjocl (TPJ+/ =5
Pa}co Gjik~a Iankg cnclch iaoegj}nkoctkgco pao{qtqoco Pconqco P}cg~kg
Glkokt (PPG+ {coe nkmqc~ jlah (galjipjg+ t~cf iankt =8 nco iaoecdq gapcnc
Panjico Octkjocl Palc{coco Ganjg~a}co (POPG+ {coe nkmqc~ jlah j}ecoktctk
p}jfatk =; nco nktchgco jlah Iao~a}k Gatahc~co 6/ Naoeco ~a}mk~o{c Pa}c~q}co
Iao~a}k Gatahc~co ]K Ojij} 34>8*IAOGAT*PA]*KX*=030 {coe nkeqocgco
cnclch kt~klch T~conc} Palc{coco Ganjg~a}co (TPG+ {coe ~a}nk}k nc}k Panjico
Octkjocl Palc{coco Ganjg~a}co (POPG+ nco T~conc} P}jtanq} Jpa}ctkjocl (TPJ+/
POPG nkmqc~ jlah j}ecoktctk p}jfatk nco nktchgco jlah Iao~a}k Gatahc~co ]K,
tancoegco TPJ nkmqc~ nk ~koegc~ }qich tcgk~ jlah p}jfatk iankt naoeco
gjj}nkoc~j} Gjik~a Iankg nco nk~a~cpgco paoeeqoccoo{c nk }qich tcgk~
~a}tamq~ jlah pkipkoco (nk}ag~q}+/
T~conc} Palc{coco Ganjg~a}co (POPG nco PPG+ ~kncg knao~kg naoeco Mqgq Cbc},
^ax~)mjjgt c~cqpqo dc~c~co gqlkch {coe nkeqocgco nk pa}eq}qco ~koeek/ Gc}aoc
T~conc} Palc{coco Ganjg~a}co ia}qpcgco clc~*mchco {coe nkkiplaiao~ctkgco
pcnc pctkao7 tancoegco mqgq cbc}, ~ax~)mjjgt, bq}ocl, mchco taikoc} icqpqo
paoeclcico p}kmcnk cnclch tamceck mchco }qbqgco*}afa}aotk nclci iao{qtqo
T~conc} Palc{coco Ganjg~a}co/
=> Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 3>48*KX*=030 ~ao~coe T~conc} Palc{coco Ganjg~a}co/h~~p2**uuu/td}kmn/dji*njd*>4050564*Njn{)Fk}iconc)=030)Pa}iaogat)Oj)3>48)IAOGAT)
PA])KX) =030)T~conc})Palc{coco)Ganjg~a}co=1 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 3>48*KX*=030 ~ao~coe T~conc} Palc{coco Ganjg~a}coPctcl 3 c{c~ 3/=6 Qoncoe Qoncoe ]K Ojij} =; ^chqo =00> Pctcl >> c{c~ 4/=5 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 3>48*KX*=030 ~ao~coe T~conc} Palc{coco Ganjg~a}coPctcl 4 c{c~ 3/=8 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 3>48*KX*=030 ~ao~coe T~conc} Palc{coco Ganjg~a}coPctcl 33/=; Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 3>48*KX*=030 ~ao~coe T~conc} Palc{coco Ganjg~a}coPctcl 4 nco Pctcl 6/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
16/32
34
T~conc} P}jtanq} Jpa}ctkjocl qo~qg p}jfatk iankt nk }qich tcgk~ nclci mao~qg
Pconqco P}cg~kg Glkokt40 ) pcnc qiqio{c ncpc~ nkcnjptk nc}k Pconqco Octkjocl
Palc{coco Ganjg~a}co (POPG+ {coe ~alch nkmqc~ jlah j}ecoktctk p}jfatk ictkoe
ictkoe, ~koeecl nkdjdjggco nco nktatqckgco naoeco gjonktk tc}coc nco
gjipa~aotk {coe cnc nk }qich tcgk~/ Mklc POPG {coe ~alch nkmqc~ jlah j}ecoktctk
p}jfatk ~a}tamq~ nco ~alch nktchgco jlah Iao~a}k Gatahc~co ]K ta}~c tatqck naoeco
gjonktk }qich tcgk~ icgc ~koeecl nktapcgc~k jlah coeej~c p}jfatk (TIF+ ~a}gck~
tamceck Pconqco P}cg~kg Glkokt (PPG+ nco nktchgco paoeeqoccoo{c nk }qich
tcgk~ jlah nk}ag~q} }qich tcgk~ ~a}tamq~/
Ociqo mklc POPG ~a}tamq~ malqi cnc c~cq ~kncg tatqck naoeco gjonktk }qich
tcgk~ c~cq nclci POPG malqi iaodco~qigco baokt pao{cgk~ {coe tatqck naoeco
gacncco apknaikjljek pao{cgk~ nk nca}ch*}qich tcgk~ ~a}tamq~ icgc p}jfatk nk
}qich tcgk~ ~a}tamq~ ucbkm iaimqc~ Pconqco P}cg~kg Glkokt (PPG+ qo~qg }qich
tcgk~ ~a}tamq~ nco nktchgco paoeeqoccoo{c nk }qich tcgk~ jlah nk}ag~q} }qich
tcgk~/ Nclci iao{qtqo POPG nc}k j}ecoktctk p}jfatk icqpqo PPG qo~qg }qich
tcgk~ ) p}jfatk iankt iaima}kgco palc{coco gap}jfatkcoo{c tadc}c afag~kf (dlkokdcl
affad~kvaoatt+ nclci hcl iaoaecggco nkceojtkt nco iaima}kgco ~a}cpk
ma}nctc}gco paonagc~co avknaoda)mctan iankdkoa /
Pa}co Gjik~a Iankg nktkok cnclch2
3/ iaimqc~ nco iaoa~cpgco fj}ic~ qiqi Pconqco P}cg~kg Glkokt
=/ iaoa~cpgco gatapcgc~co ~koegc~ avknaot {coe cgco nkpa}eqocgco nk ]T
4/ iaoegjipklctk PPG {coe ~alch talatck
>/ ia}agjiaonctkgco PPG gapcnc nk}ag~q} qo~qg paoeatchco paoeeqocco
PPG ~a}tamq~ nk }qich tcgk~
1/ ialcgtcocgco cqnk~ iankt naoeco iaipa}eqocgco PPG
6/ iaoa~cpgco gauaocoeco glkokt p}jfatk iankt
40 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 34>8*IAOGAT*PA]*KX*=030
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
17/32
3>
Naoeco ~a}mk~o{c Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 511*Iaogat*KV*=033,
icgc Gapq~qtco Iao~a}k Gatahc~co Ojij} 55=*Iaogat*TG*VK*=00= ~ao~coe
Panjico Pa}c~q}co Ko~a}ocl ]qich Tcgk~ ( Hjtpk~cl M{ Lcut+ tapcobcoe iaoeaock
paoec~q}co t~cf iankt, Gapq~qtco Iao~a}k Gatahc~co Ojij}
>;6*Iaogat*TG*KV*=001 ~ao~coe Panjico Cqnk~ Iankt nco Gapq~qtco Iao~a}k
Gatahc~co Ojij} 643*Iaogat*TG*VKK*=001 ~ao~coe Panjico Pao{qtqoco
Pa}c~q}co Ko~a}ocl T~cf Iankt nkdcmq~ nco nko{c~cgco ~kncg ma}lcgq43 nco ta~kcp
}qich tcgk~ hc}qt iao{atqckgco naoeco pa}c~q}co ~a}tamq~ talcimc~o{c ~coeecl 1
Ojvaima} =033 (6 mqlco tabcg nkqoncoegcoo{c pa}c~q}co ~a}tamq~+4=/
Pa}c~q}co Iao~a}k Gatahc~co ~a}tamq~ ma}~qbqco qo~qg iaoec~q} ~c~c galjlc glkokt
(dlkokdcl ejva}ocoda + {coe mckg cec} iq~q palc{coco iankt nco gatalcic~co
pctkao nk}qich tcgk~ lamkh ~a}bciko nco ~a}lkonqoek ta}~c iaoec~q}
pao{alaoeec}cco gjik~a iankg nk ta~kcp }qich tcgk~ nclci }coegc paokoegc~co
p}jfatkjoclktia t~cf iankt/ 44 Tahkoeec tqnch talc{cgo{c ta~kcp }qich tcgk~
iaimqc~ ^c~c Galjlc Gj}pj}c~ ( Dj}pj}c~a Ejva}ocoda+ nco ^c~c Galjlc Glkokt
(Dlkokdcl Ejva}ocoda+ tamceck gjotagqaotk ~koncg lcobq~ nc}k Pa}c~q}co Ko~a}oc
T~cf Iankt (Iankdcl T~cf M{lcut+ nco Pa}c~q}co Ko~a}oc ]qich Tcgk~ (Hjtpk~cl
M{lcut+/
^a}lapct nc}k gaonclc paoeeqocco Dlkokdcl Pc~huc{t tamceck palaoegcp KOC)
DME7 kiplaiao~ctk Dlkokdcl Pc~huc{t tcoec~ ma}icofcc~ mcek p}jfatk nclci
iaima}kgco palc{coco, paonknkgco icqpqo paoalk~kco nk }qich tcgk~
tamceckicoc ncpc~ nklkhc~ nclci ecimc} 1 tcipck 5 ma}kgq~/
43 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 511*Iaogat*KV*=033 Pctcl =0/4= Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 511*Iaogat*KV*=033 Pctcl 3;/44 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 511*Iaogat*KV*=033 Pctcl =/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
18/32
31
Ecimc} 1/ Kiplaiao~ctk Dlkokdcl Pc~huc{t nclci mkncoe palc{coco nk }qich
tcgk~/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
19/32
36
Ecimc} 6/ Kiplaiao~ctk Dlkokdcl Pc~huc{t qo~qg paoalk~kco nk }qich tcgk~/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
20/32
35
Ecimc} 5/ Kiplaiao~ctk Dlkokdcl Pc~huc{t nkgck~co naoeco ctatiao paoklckcoqo~qg pata}~c nknkg ichctktuc nco pata}~c p}je}ci njg~a} tpatkclkt nk }qich tcgk~icqpqo }qich tcgk~ babc}koe paonknkgco/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
21/32
38
Gjotap/ gjot~}qgtk icqpqo ijnal kiplaiao~ctk Dlkokdcl Pc~huc{t tadc}c ~kncg
lcoetqoe tamceckicoc nkq~c}cgco nkc~ct mchuc2
Dlkokdcl Pc~huc{t tamceck kot~}qiao palc{coco ma}fjgqt gapcnc pctkao
(pc~kao~)fjdqtan dc}a+ , ~a}ko~ae}ctk, ma}gatkocimqoeco nc}k pctkao
ictqg nk}cuc~ tcipck pqlcoe taimqh (djo~koqjqt dc}a+, balct cgco
njg~a}*pa}cuc~ paocoeeqoe bcucm pctkao (NPBP*PPBP+ tamceck nq~{ jf
dc}a, q~klk~ct paia}kgtcco paoqobcoe, paoeeqocco jmc~ jmc~co ~a}ictqg
co~kmkj~kgc, p}jtanq} ~koncgco jpa}ctk, co~ktkpctk gaiqoegkoco ~a}bcnko{c
iankdcl a}}j}t (lc~ao nco cg~kf, o{c}kt ~a}bcnk icqpqo gabcnkco ~kncg
nkhc}cpgco*G^N+ nco paodaechco gaiqoegkoco dana}c (hc}it+ ta}~c
kofagtk ojtjgjikcl nclci }coegc gatalcic~co pctkao (pc~kao~ tcfa~{+,
iaona~agtk nkok ~k~kg ~k~kg pj~aotkcl ma}ktkgj talcic p}jtat lc{coco
pa}cuc~co pctkao (~}cda}t ia~hjnjlje{+ nclci }coegc icocbaiao }ktkgj
(}ktgt icoceaiao~+, }aodcoc paiqlcoeco pctkao (pc~kao~ nktdhc}ea+,
qpc{c paokoegc~co iq~q lc{coco ma}gatkocimqoeco (djo~koqjqt sqclk~{
kip}jvaiao~+ mckg naoeco paonagc~co ~ahokg ^JD (^haj}{ jf Djot~}cko~t+
qo~qg tkt~ai icqpqo konkvknq p}jfatk, paoqlqtq}co gkoa}bc (pa}fj}icoda+
konkvknq p}jfatk icqpqo galjipjg (~aci)uj}g+/
Ia}qpcgco tqc~q }coegckco tkt~ai {coe ncpc~ nkpa}eqocgco tamceck kot~}qiao
qo~qg iaiaoqhk pa}t{c}c~co paoklckco Cg}ank~ctk nc}k Gjik~a Cg}ank~ctk ]qich
Tcgk~ (GC]T+ va}tk mc}q icqpqo nc}k Bjko~ Djiikttkjo Ko~a}oc~kjocl fj}
Hjtpk~cl (BDK+va}tk =033 qo~qg t~conc} t~conc} nclci Tad~kjo K/ Pc~kao~ Dao~a}an
T~conc}n icqpqo nclci Tad~kjo KK/ Hacl~hdc}a J}ecokrc~kjo Icoceaiao~ T~conc}n tamceckicoc klqt~}ctk Ecimc} 8 tcipck 30 ma}kgq~/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
22/32
3;
Ecimc} 8/ Dlkokdcl Pc~huc{t nco va}tk BDK =033 Cdd}ank~c~kjo T~conc}nt
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
23/32
=0
Ecimc} ;/ Tkt~aic~kgc nclci va}tk BDK =033 Hjtpk~cl T~conc}nt nco Paoklckcoo{c
Oj~Ia~
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
24/32
=3
Ecimc} 30/ Dlkokdcl Pc~huc{t nco ~ahokg ^}cda} Ia~hjnjlje{ {coe nkeqocgcojlah tq}vakj} nclci }coegc Cg}ank~ctk va}tk BDK =033
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
25/32
==
P}kotkp p}kotkp nclci iao{qtqo Dlkokdcl Pc~huc{t
Dlkokdcl Pc~huc{t (DP+ cnclch tqc~q gjotap pa}aodcocco palc{coco ~a}pcnq
{coe ia}coegqi ta~kcp lcoegch {coe nkma}kgco gapcnc pctkao ma}nctc}gco
t~conc} palc{coco iankt nco ctqhco gapa}cuc~co {coe ma}mctkt mqg~k naoeco
hctkl {coe ~a}qgq} nco nclci bcoegc ucg~q ~a}~ao~q talcic nk }qich tcgk~/ 4>,41,46
Nclci iaimqc~ Dlkokdcl Pc~huc{t paocoecoco gctqt pctkao }cuc~ kocp nk }qich
tcgk~ hc}qt ma}tkfc~2
c/ Talq}qh gaekc~co palc{coco {coe nkma}kgco hc}qt tadc}c ~a}pcnq*ko~ae}ctk
nco ma}j}kao~ctk fjgqt ~a}hcncp pctkao (Pc~kao~ Fjdqtan Dc}a+ ta}~c
ma}gatkocimqoeco (djo~koqjqt jf dc}a+
m/ Ialkmc~gco talq}qh p}jfatk (njg~a}, pa}cuc~*mknco, paoc~c, lcmj}c~j}kt nco
fc}ictkt+
d/ Nclci mc~ctco ucg~q {coe ~alch nk~ao~qgco tatqck naoeco gacncco
pa}bclcoco pao{cgk~ pctkao nco nkdc~c~ nclci mao~qg pa}kjna hc}kco (qo~qg
gctqt }cuc~ kocp+ c~cq bci (qo~qg gctqt ecuc~ nc}q}c~ nk qok~ aia}eaotk+/
n/ Paodc~c~co DP talq}qh gaekc~co palc{coco {coe nkma}kgco gapcnc pctkao
tadc}c ~a}pcnq nco ma}gatkocimqoeco ~a}tamq~ nclci mao~qg njgqiao
{coe ia}qpcgco mcekco nc}k ]agci Iankt/
a/ Ta~kcp pao{kipcoeco lcoegch nclci paoa}cpco DP nkdc~c~ tamceck vc}kcot
nco nklcgqgco gcbkco coclktkt nclci mao~qg cqnk~/
f/ Vc}kcot ~a}tamq~ ncpc~ gc}aoc gjonktk pa}bclcoco pao{cgk~, pao{cgk~
pao{a}~c c~cq gjiplkgctk icqpqo gatclchco iankt (iankdcl a}}j}t+ /
4> Fk}iconc N/ Panjico Pao{qtqoco Dlkokdcl Pc~huc{t nclci }coegc kiplaiao~ctk Tkt~ai N]EtDctaikx nk }qich tcgk~/ Nktcipckgco nclci Tkncoe Plaoj Gjik~a Iankg ]T Fc~icuc~k, Bcgc}~c
5 Jg~jma} =001/41 Fk}iconc N/ Dlkokdcl Pc~huc{t2 Pa}co p}jfatk iankt nclci }coegc iao{qtqo Tkt~ai N]Et
Dctaikx nk }qich tcgk~/ Nktcipcgco pcnc gqobqoeco lcpcoeco ga ]TQP Cnci Iclkg Ianco== Nataima} =001, ]TQP Hctco Tcnkgko Mconqoe =4 Nataima} =001 nco Avclqctk Pao{qtqocoDlkokdcl Pc~huc{t nclci }coegc pao{aipq}occo Panjico N]Et Dctaikx Napgat ]K, Hj~alE}con Daipcgc Bcgc}~c =; Nataima} =001/
46 Fk}iconc N, P}c~kuk Conc{cok, Oq}ckok K}ic Tqtco~k, T}ka Aoeec} GN ngg/ Dlkokdcl Pc~huc{tGatahc~co Cocg nclci }coegc kiplaiao~ctk Tkt~ai N]Et Dctaikx nk ]T Fc~icuc~k, Bcgc}~c
=006/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
26/32
=4
e/ Vc}kcot ~a}tamq~ nkpa}eqocgco tamceck tclch tc~q pc}cia~a} nclci }coegc
iaipa}~chcogco nco iaokoegc~gco iq~q palc{coco/
Dlkokdcl Pc~huc{t ~a}tamq~ ncpc~ ia}qpcgco tqc~q T~conc} P}jtanq} Jpa}ctkjocl
{coe ia}coegqi2
c/ P}jfatk iankt2 T~conc} Palc{coco Iankt nc}k ta~kcp Galjipjg T~cf
Iankt*T~cf Iankt Fqoetkjocl (TIF+ glkokt nco paoqobcoe/
m/ P}jfatk gapa}cuc~co2 Ctqhco Gapa}cuc~co
d/ P}jfatk fc}ictk2 Qok~ Njta Nckl{ nco T~jp J}na}koe
n/ Clq} Palc{coco Pctkao ]cuc~ Kocp nco Jpa}ctk nc}k Tkt~ai Galjipjg T~cf Iankt*T~cf Iankt Fqoetkjocl (TIF+, Kot~clctk nco Tkt~ai Icocbaiao
]qich Tcgk~/
Lcoegch lcoegch pao{qtqoco Dlkokdcl Pc~huc{t
Lcoegch lcoegch nclci iao{qtqo Fj}ic~ Dlkokdcl Pc~huc{t {coe hc}qt
nkpa}hc~kgco2
3/ Gjipjoao {coe hc}qt nkdcgqp tamceckicoc nafkoktk nc}k Dlkokdcl
Pc~huc{t
=/ Icofcc~gco nc~c {coe ~alch cnc nk lcpcoeco }qich tcgk~ nco gjonktk
ta~aipc~ 45 tapa}~k nc~c Lcpj}co ]L= (Nc~c Gacncco Ij}mknk~ct Pctkao+
{coe nkmqc~ ta~kcp }qich tcgk~ ma}nctc}gco Mqgq Pa~qobqg Paoektkco,
Paoejlchco nco Pao{cbkco Nc~c ]qich Tcgk~ 48 nco taotqt hc}kco qo~qg2
c/ Paoa~cpco bqnql*~jpkg Dlkokdcl Pc~huc{t {coe cgco nkmqc~/
m/ Paoa~cpco lcic hc}k }cuc~/
45 Fk}iconc N/ Gjnafkgctk KDN 30 nco KDN ; DI2 konkgc~j} iq~q }agci iankg nclci }coegciaokoegc~gco iq~q palc{coco }qich tcgk~/ Nktcipckgco pcnc Tjtkclktctk Pjlc Tkt~ai
Kofj}ictk Icocbaiao ]qich Tcgk~ / Nktalaoeec}cgco jlah Nk}ag~j}c~ Baona}cl Mkoc Palc{coco Iankg
Napgat ]Knk Hj~al Pcoehaec} Mconqoe 3)4 Bqok =006/
48 Napc}~aiao Gatahc~co ]K/ Mqgq Pa~qobqg Paoektkco, Paoejlchco nco Pao{cbkco Nc~c ]qichTcgk~/ Nk}ag~j}c~ Baona}cl Mkoc Palc{coco Iankg Napgat ]K, Bcgc}~c =001/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
27/32
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
28/32
=1
Ta~kcp vc}kcot {coe nkncpc~gco cgco nklcgqgco ~koncg lcobq~ nclci mao~qg
palcgtcocco cqnk~ iankt tamceckicoc {coe nkcobq}gco nclci Qoncoe Qoncoe ]K
Ojij} =; ^chqo =00> nco Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij}
511*Iaogat*Pa}*KV*=033/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
29/32
=6
Gatkipqlco2
Nc}k q}ckco tkoegc~ nkc~ct naoeco hco{c talaimc} Dlkokdcl Pc~huc{t )
ia}qpcgco tqc~q kot~}qiao {coe gjip}ahaotkf ia}coegqi tadc}c ~a}pcnq mkncoe
palc{coco, paonknkgco nco paoalk~kco icqpqo cg}ank~ctk ta}~c mklc nk~kobcq
nc}k taek agjojik gatahc~co ncpc~ ialcgtcocgco afktkaotk paimkc{cco naoeco
iaicofcc~gco tajp~kicl iqoegko hc}k }cuc~ pctkao, iaoealkikoctk paia}kgtcco
paoqobcoe*lcmj}c~j}kqi*~koncgco {coe ~kncg nkpa}lqgco, iaoeeqocgco jmc~
jmc~cco (~a}q~cic co~kmkj~kg+ tatqckavknaoda)mctan7 tahkoeec palc{coco afag~kf
nktcipkoe ~kncg iaimancgco lc~c} malcgcoe pctkao gc}aoc fjgqt gapcnc pctkao
nco pao{cgk~o{c (gama}cnklco*agqk~k+ nco tagclkeqt iaiaoqhk talq}qh ~kec~qbqco nc}k Qoncoe Qoncoe ]K Ojij} =; ^chqo =00> nco aipc~ ~qbqco
Qoncoe Qoncoe ]K Ojij} >> ^chqo =00;/
Naikgkco pqlc mcek ]qich Tcgk~ Paonknkgco, Dlkokdcl Pc~huc{t ncpc~
nkpa}eqocgco tamceck kot~}qiao nclci Iankdcl Anqdc~kjo Cttattiao~t ~koegc~
glkokt nclci mao~qg Uj}gplcda)mctan Cttattiao~ (UMC+ qo~qg Lje)mjjg, Ikok)
DAX, NJPT, Dm)N, 460)nae}aa Cttattiao~ (Ikok)PC^+, Pj}~fjlkj nco Td}kp~
Djodj}ncoda ^at~ (TD^+ {coe tqnch ia}qpcgco gjipjoao nclci Cg}ank~ctk
T~conc} Paonknkgco Njg~a} nco Njg~a} Tpatkclkt nk Konjoatkc/
Mchgco mklc nklcgtcocgco Dlkokdcl Pc~huc{t tadc}c gjotkt~ao nkicoc cgco
nkncpc~gco nc~c nc~cdjt~)uakeh~, dctaikx konax nco mcta)}c~a tadc}c laoegcp
(qo~qg ikd}j)t{t~ai + cgco ncpc~ nktqtqo tqc~q Oc~kjocl Hacl~h Cddjqo~t tahkoeec
Qokva}tcl Djva}cea cgco lamkh iqnch ~a}dkp~c nco Qoncoe Qoncoe ]K Ojij}
>0 ^chqo =00> ta}~c Qoncoe Qoncoe ]K Ojij} => ^chqo =033 qo~qg mkncoe
gatahc~co ~a}uqbqn (tadc}c icd}j)t{t~ai +/
^a}kic gctkh, taijec ma}icofcc~/Tq}cmc{c, 8 Nataima} =03=Njn{ Fk}iconcGa~qc Gjik~a Iankg ]TQP Fc~icuc~k Bcgc}~c/h~~p2**uuu/td}kmn/dji*Gjik~a!=0Iankg
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
30/32
=5
LCIPK]CO2
PCONQCO P]CG^KG GLKOKT (PPG+
]TQN N] IJHCICN TQUCONHKATQ]CMC[C BCUC ^KIQ]
=03= =03>
//////////////////////////////
3/ Paoea}~kco (Nafkoktk+
=/ Cocioatkt
4/ Paia}kgtcco Fktkg
>/ G}k~a}kc Nkceojtkt 3/ =/ 4/ >/ 1/ /////
1/ Nkceojtkt 6/ Nkceojtkt Mconkoe 3/
=/ 4/
5/ Paia}kgtcco Paoqobcoe 3/ =/ 4/ >/
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
31/32
=8
8/ ^a}cpk 3/ =/ 4/ >/ 1/ /////
;/ Anqgctk 3/ =/ 4/ >/ 1/ /////
30/ P}jeojtkt Cn vk~ci 2 nqmkc cn mjoci*iclci
Cn tcoc~kjoci 2 nqmkc cn mjoci*iclciCn fqietkjoci 2 nqmkc cn mjoci*iclci33/ ^koegc~ Avknaot K*KK*KKK*KV3=/ ^koegc~ ]agjiaonctk C*M*D34/ Paoalcch G}k~kt 3/
=/ 4/ >/
3>/ Konkgc~j} Iankt
31/ Gapqt~cgcco 3/ =/ 4/ >/ 1/ /////
Tq}cmc{c, /=03=
Ga~qc Gjik~a Iankg Ga~qc TIF///////////////////////////////////////////////
//////////////////////////////////// //////////////////////////////////////
Nk}ag~q} ]TQN N} Ijhcicn Tquconka, Tq}cmc{cBcuc ^kiq}
///////////////////////////////////////////////////////
7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember
32/32
40
DLKOKDCL PC^HUC[T
]TQN N] IJHCICN TQUCONHKA GJ^C TQ]CMC[C
/
Ocic Pctkao2
Qiq}2
Ma}c~ Mcnco2//ge
^koeek Mcnco2//di
Ojij} ]agci Iankt2/
Nkceojtkt Cucl2 / Gjna KDN 30 2 ]aodcoc }cuc~ 2 hc}k
Cg~kvk~ct Palc{coco]/ ]cuc~
/^el*Bci ictqg2/
^el*Bci galqc}2/
Lcic ]u~/// hc}k
Galct2//
^c}kf*h} (]p+2/
Mkc{c (]p+
Hc}k ]cuc~ 3 Hc}k ]cuc~ = Hc}k ]cuc~ 4 Hc}k ]cuc~ > Hc}k ]cuc~ 1Hc}k Tcgk~2 Hc}k Tcgk~2 Hc}k Tcgk~2 Hc}k Tcgk~2 Hc}k Tcgk~2
Nkceojtkt2
Pao{cgk~ Q~cic / Pao{cgk~ Pao{a}~c / Gjiplkgctk /
Ctattiao Glkokt2Paia}kgtcco njg~a} / //Gjotql~ctk / //
Paia}kgtcco Paoqobcoe2 / //^koncgco2 / //Jmc~ jmc~co2
//
/
/
/
////
//
////
//
////
//
////
//
Oq~}ktk2 / //Ijmklktctk2 / //Hctkl(Jq~djia+ 2
// / // / // /
Paonknkgco*]aodcocPaiqlcoeco2
/
Vc}kcot2 /
Bqilch Mkc{c //Pa}cuc~ (PPBP+
Nkceojtkt Cghk}2 Gjna KDN 30 Baokt koncgco2 Gjna KDN ;
NPBP2
Q~cic //
NPBP Jpa}ctk2
Pao{a}~c //
NPBP Coat~atk///////////////////////
/ // //
Va}kfkgc~j}2
Gjiplkgctk // //